Anthropic IPO filing flags healthcare, drug discovery as growth bets

Anthropic’s S-1 filing names healthcare and life sciences as new markets, citing Claude’s drug discovery use and $2 trillion in expected 2026 pharma spend.

First reported by Becker's Hospital Review. This page is a short excerpt; the full text is theirs.